XBiotech Inc
XBIT
NASDAQ
Biotechnology
$2.30
USD
-0.03 (-1.29%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $75.00M
Volume 46.5K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-40.16M
TTM
-1.9%
YoY
Operating Cash Flow
$-42.17M
TTM
-38.3%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 1.9 | 1.0 | 1.0 | 4.4 | 1.1 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 13.6 | 6.3 | 6.0 | 29.8 | 6.3 |
Operating Income | -13.6 | -6.3 | -6.0 | -29.8 | -6.3 |
EBITDA | -13.1 | -5.9 | -5.6 | -29.4 | -5.9 |
Other Income / Expense | 1.3 | 3.1 | -1.3 | 1.7 | -0.1 |
Total Other Income / Expense | 2.7 | 4.6 | 0.1 | 2.9 | 0.8 |
Income Before Income Taxes | -10.9 | -1.7 | -5.9 | -26.8 | -5.5 |
Income Taxes | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 |
Net Income | -10.9 | -1.8 | -6.0 | -26.9 | -5.5 |
Consolidated Net Income / Loss | -10.9 | -1.8 | -6.0 | -26.9 | -5.5 |
Net Income Attributable to Common Shareholders | -10.9 | -1.8 | -6.0 | -26.9 | -5.5 |
Basic EPS | -$0.36 | -$0.06 | -$0.20 | -$0.88 | -$0.18 |
Diluted EPS | -$0.36 | -$0.06 | -$0.20 | -$0.88 | -$0.18 |
Basic Shares Outstanding | 30.5M | 30.5M | 30.5M | 30.5M | 30.5M |
Diluted Shares Outstanding | 30.5M | 30.5M | 30.5M | 30.5M | 30.5M |